Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@d_stock07734 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1660707117722902539.png) @d_stock07734 d_stock

d_stock posts on X about $nwbo, $rvmd, cest, solve the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1660707117722902539/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1660707117722902539/c:line/m:interactions.svg)

- X Week XXXXX +586%
- X Month XXXXXX -XX%
- X Months XXXXXXX +401%
- X Year XXXXXXX +129%

### Mentions: X [#](/creator/twitter::1660707117722902539/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1660707117722902539/c:line/m:posts_active.svg)

- X Month XX -XX%
- X Months XXX +249%
- X Year XXX +155%

### Followers: XXX [#](/creator/twitter::1660707117722902539/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1660707117722902539/c:line/m:followers.svg)

- X Week XXX +0.49%
- X Month XXX +1.50%
- X Months XXX +3.20%
- X Year XXX +21%

### CreatorRank: undefined [#](/creator/twitter::1660707117722902539/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1660707117722902539/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[$nwbo](/topic/$nwbo), [$rvmd](/topic/$rvmd), [cest](/topic/cest), [solve](/topic/solve), [invested](/topic/invested), [$iova](/topic/$iova)

**Top accounts mentioned or mentioned by**
[@andrewcaravello](/creator/undefined) [@metacollectiveg](/creator/undefined) [@dcvaxdaw](/creator/undefined) [@mdendream](/creator/undefined) [@maveric92283613](/creator/undefined) [@alphavestcap](/creator/undefined) [@flemmingbruce](/creator/undefined) [@hoffmann6383](/creator/undefined) [@exosome](/creator/undefined) [@peterbrit](/creator/undefined) [@investor2013us](/creator/undefined) [@patrickwalsh14](/creator/undefined) [@apwriter](/creator/undefined) [@bunastarebio](/creator/undefined) [@pratapsinghmd](/creator/undefined) [@immortabio](/creator/undefined) [@smith348572](/creator/undefined) [@sharpie510](/creator/undefined) [@bio99bio99](/creator/undefined) [@ninakd](/creator/undefined)

**Top assets mentioned**
[Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova)
### Top Social Posts
Top posts by engagements in the last XX hours

"$NWBO $RVMD is going to face competition from Incyte. INCB161734 (KRAS G12D) Preliminary Phase X Results Of INCB161734 A Novel Oral KRAS G12D Inhibitor In Patients With Advanced Or Metastatic Solid Tumors (Session Title: Proffered paper session: Developmental therapeutics. October XX 8:45 10:20 a.m. ET 2:45 4:20 p.m. CEST. Abstract #916O.)"  
[X Link](https://x.com/d_stock07734/status/1979292412758626542)  2025-10-17T21:04Z XXX followers, 3331 engagements


"$NWBO Maybe $RVMD is not going to face competition from Incyte since Baker Brothers own X% of $RVMD. MOONRAY-01 a phase X study of LY3962673 a potent orally bioavailable and selective KRAS G12D inhibitor in KRAS G12D-mutant solid tumors. A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification HER2 mutation/amplification HER3/4 mutation or KRAS mutation Vivek Subbiah: Talk about shaking the field of cancer research- cracking KRAS"  
[X Link](https://x.com/d_stock07734/status/1979369099323953267)  2025-10-18T02:09Z XXX followers, 3720 engagements


"It is interesting Amgen invested in the development of Curate platform and Phillip Tagari Amgens Vice President of Research joined the Scientifics Board of Directors in May 2021. Did Roger Perlmutter join Eikon in May 2021 too Both Merck and Amgen were trying to complete their biologic manufacturing facilities at West Point and New Albany respectively by working like 24/7. Merck didn't join other BPs in the bidding war to acquire Horizon Therapeutics which had the Interferon Gamma-1b. These could be randomly separate events. If there were some connections it would be really cool GPB"  
[X Link](https://x.com/d_stock07734/status/1996409944833175851)  2025-12-04T02:43Z XXX followers, XXX engagements


"@bullishbruk You are promoting $IOVA too. What makes $IOVA your top pick"  
[X Link](https://x.com/d_stock07734/status/1998098538644070789)  2025-12-08T18:33Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@d_stock07734 Avatar @d_stock07734 d_stock

d_stock posts on X about $nwbo, $rvmd, cest, solve the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXXXX +586%
  • X Month XXXXXX -XX%
  • X Months XXXXXXX +401%
  • X Year XXXXXXX +129%

Mentions: X #

Mentions Line Chart

  • X Month XX -XX%
  • X Months XXX +249%
  • X Year XXX +155%

Followers: XXX #

Followers Line Chart

  • X Week XXX +0.49%
  • X Month XXX +1.50%
  • X Months XXX +3.20%
  • X Year XXX +21%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence stocks

Social topic influence $nwbo, $rvmd, cest, solve, invested, $iova

Top accounts mentioned or mentioned by @andrewcaravello @metacollectiveg @dcvaxdaw @mdendream @maveric92283613 @alphavestcap @flemmingbruce @hoffmann6383 @exosome @peterbrit @investor2013us @patrickwalsh14 @apwriter @bunastarebio @pratapsinghmd @immortabio @smith348572 @sharpie510 @bio99bio99 @ninakd

Top assets mentioned Revolution Medicines, Inc. Common Stock (RVMD) Iovance Biotherapeutics, Inc. Common Stock (IOVA)

Top Social Posts

Top posts by engagements in the last XX hours

"$NWBO $RVMD is going to face competition from Incyte. INCB161734 (KRAS G12D) Preliminary Phase X Results Of INCB161734 A Novel Oral KRAS G12D Inhibitor In Patients With Advanced Or Metastatic Solid Tumors (Session Title: Proffered paper session: Developmental therapeutics. October XX 8:45 10:20 a.m. ET 2:45 4:20 p.m. CEST. Abstract #916O.)"
X Link 2025-10-17T21:04Z XXX followers, 3331 engagements

"$NWBO Maybe $RVMD is not going to face competition from Incyte since Baker Brothers own X% of $RVMD. MOONRAY-01 a phase X study of LY3962673 a potent orally bioavailable and selective KRAS G12D inhibitor in KRAS G12D-mutant solid tumors. A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification HER2 mutation/amplification HER3/4 mutation or KRAS mutation Vivek Subbiah: Talk about shaking the field of cancer research- cracking KRAS"
X Link 2025-10-18T02:09Z XXX followers, 3720 engagements

"It is interesting Amgen invested in the development of Curate platform and Phillip Tagari Amgens Vice President of Research joined the Scientifics Board of Directors in May 2021. Did Roger Perlmutter join Eikon in May 2021 too Both Merck and Amgen were trying to complete their biologic manufacturing facilities at West Point and New Albany respectively by working like 24/7. Merck didn't join other BPs in the bidding war to acquire Horizon Therapeutics which had the Interferon Gamma-1b. These could be randomly separate events. If there were some connections it would be really cool GPB"
X Link 2025-12-04T02:43Z XXX followers, XXX engagements

"@bullishbruk You are promoting $IOVA too. What makes $IOVA your top pick"
X Link 2025-12-08T18:33Z XXX followers, XXX engagements

@d_stock07734
/creator/twitter::d_stock07734